Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
38.80
-0.27 (-0.69%)
At close: Aug 1, 2025, 4:00 PM
38.99
+0.19 (0.49%)
After-hours: Aug 1, 2025, 7:45 PM EDT
Augmedix Market Cap
Legend Biotech has a market cap or net worth of $7.15 billion as of August 1, 2025. Its market cap has decreased by -29.83% in one year.
Market Cap
7.15B
Enterprise Value
6.51B
1-Year Change
-29.83%
Ranking
Category
Stock Price
$38.80
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from $4.79B to $7.15B, an increase of 49.40%. That is a compound annual growth rate of 8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 7.20B | 20.62% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | 3.74B | -21.96% |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.56B |
| Johnson & Johnson | 400.70B |
| AbbVie | 342.01B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 231.97B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.73B |
| Novo Nordisk | 221.96B |